Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo
ACS Chemical Neuroscience · 06.03.2024 · 15 (5) · 955-971
DOI: 10.1021/acschemneuro.3c00656 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Neuroscience, online erschienen am 19.02.2024. Verfasst von Claudia Mugnaini und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy. Hauptthemen laut MEDLINE: Neuroprotective Agents, Neuroblastoma, Alzheimer Disease, Cognitive Dysfunction. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 80 Literaturangaben. Gefördert von: Ministero dell'Universit? e della Ricerca.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Chemistry and Pharmacy, University of Siena, 53100 Siena, Italy.
- Department of Food and Drug, University of Parma, 43124 Parma, Italy.
- Department of Pharmacy-Pharmaceutical Sciences, University of Bari Aldo Moro, 70125 Bari, Italy.
- Institute of Biomolecular Chemistry, National Research Council of Italy, 80078 Pozzuoli, Naples ,Italy.
- Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), Section of Pharmacology and Toxicology, University of Florence, 50121 Florence, Italy.
- Department of Experimental Medicine, Division of Pharmacology, University of Campania "L. Vanvitelli″, 80138 Naples, Italy.
ORCID-Profile: Claudia Mugnaini, Antonella Brizzi, Riccardo Castelli, Modesto de Candia, Orazio Nicolotti, Ali Mokhtar Mahmoud, Alessia Ligresti, Federico Corelli
Förderung
- Ministero dell'Universit? e della Ricerca
Zitieren
APA
Mugnaini, C., Brizzi, A., Paolino, M., Scarselli, E., Castelli, R., de Candia, M., Gambacorta, N., Nicolotti, O., Kostrzewa, M., Kumar, P., Mahmoud, A. M., Borgonetti, V., Iannotta, M., Morace, A., Galeotti, N., Maione, S., Altomare, C. D., Ligresti, A., & Corelli, F. (2024). Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. ACS Chemical Neuroscience, 15(5), 955-971. https://doi.org/10.1021/acschemneuro.3c00656
Vancouver
Mugnaini C, Brizzi A, Paolino M, Scarselli E, Castelli R, de Candia M, et al. Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo. ACS Chemical Neuroscience. 2024;15(5):955-971. doi:10.1021/acschemneuro.3c00656
BibTeX
@article{Mugnaini2024,
author = {Mugnaini, Claudia and Brizzi, Antonella and Paolino, Marco and Scarselli, Enrico and Castelli, Riccardo and de Candia, Modesto and Gambacorta, Nicola and Nicolotti, Orazio and Kostrzewa, Magdalena and Kumar, Poulami and Mahmoud, Ali Mokhtar and Borgonetti, Vittoria and Iannotta, Monica and Morace, Andrea and Galeotti, Nicoletta and Maione, Sabatino and Altomare, Cosimo D and Ligresti, Alessia and Corelli, Federico},
title = {Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo},
journal = {ACS Chemical Neuroscience},
year = {2024},
volume = {15},
number = {5},
pages = {955--971},
doi = {10.1021/acschemneuro.3c00656}
}
EUVIMED